Active Ingredient: HYDROCHLOROTHIAZIDE; PINDOLOL
Proprietary Name: VISKAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018872
Product Number: 002
Approval Date: Jul 22, 1987
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Discontinued
Patent and Exclusivity Information